파마유니티상사

비상장계속사업자

PharmaUnity Co.,Ltd

임두환

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

파마유니티상사

Business Reg. No. 1048602911 · CEO 임두환

I.Investment Overview

Target파마유니티상사 (1048602911)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명파마유니티상사
영문명PharmaUnity Co.,Ltd
대표자임두환
사업자등록번호1048602911
법인등록번호1101113512872
설립일2006.08.22
종업원수3명

V.Workforce

3

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW158.72021213.520221532023227.8202494.82025
영업이익100M KRW0.920213.120220.1202310.52024-4.72025
순이익100M KRW2.120214.320220.3202310.92024-5.62025
Item20252024202320222021
자산총계110.1억원164.7억원111.6억원136.6억원113.8억원
부채총계65.4억원114.3억원72.1억원97.2억원78.7억원
자본총계44.8억원50.4억원39.5억원39.4억원35.1억원
매출액94.8억원227.8억원153억원213.5억원158.7억원
영업이익-4.7억원10.5억원1,465만원3.1억원8,676만원
순이익-5.6억원10.9억원2,517만원4.3억원2.1억원

VII.Financial Ratios

FY2025 basis

-4.95%

영업이익률

-5.93%

순이익률

-5.11%

ROA

-12.56%

ROE

146.01%

부채비율

40.65%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

파마유니티상사 투심보고서 | Alpha Lenz